A study of retinal microvascular changes in Diabetic Macular Edema using the swept â€ source optical coherence tomography angiography (OCTA) after being treated with Anti-Vascular endothelial growth factors (Anti-VEGF)

Ratchadapiseksompot Endowment Fund0 sites40 target enrollmentOctober 10, 2016

Overview

Phase: Phase 3
Intervention: Not specified
Conditions: DMEMicroaneurysm changesEnlarged FAZ ZoneCapillary non perfusion zone
Sponsor: Ratchadapiseksompot Endowment Fund
Enrollment: 40
Status: Recruiting
Last Updated: last year

No summary available.

Registry

who.int

Start Date

October 10, 2016

End Date

October 18, 2017

Last Updated

last year

Study Type

Observational

Sex

All

Sponsor

Ratchadapiseksompot Endowment Fund

•\- Patients diagnosed with Diabetic Macular Edema (DME).
•\- Age \> 18 years of age who have signed an inform consent.
•\- Candidates to be treated with Intravitreous Anti\-VEGF ( Aflibercept , Bevacizumab and Ranibizumab )
•\- No history of Anti\-VEGF treatment within 3 months.
•\- No history of retina surgery.

•\- Presence of severe media opacities.
•\- Patients who have other disease: monoculus, eye injuries , glaucoma, uveitis, retinal vein occlusion, retinal arterial occlusion, hereditary and degenerative macular disease, retinal and choroidal detachment.
•\- Any previous treatment for DME e.g. Focal / Grid LASER , IVT steroid injection/implant with in 6 months.